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Abstract
Existing prostate cancer cell lines have been derived
from late stages of human prostate cancer. In this paper,
we present two cell lines generated from prostatic
intraepithelial neoplasia (PIN), the precursor lesion for
prostate adenocarcinoma. Pr-111 and Pr-117 were
established from PIN lesions that developed in the
C3(1) /Tag transgenic model of prostate cancer. Pr-111
and Pr-117 cells express simian virus 40 large T antigen
(SV40 Tag) and are immortalized in culture, distinguish-
ing them from normal prostate cells. The growth rates of
these two cell lines are quite different; with Pr-111 cells
growing much more slowly (doubling time approxi-
mately 40 hours) compared to Pr-117 cells (doubling
time approximately 22 hours), and also show signifi-
cantly different growth rates in different media. Both
prostate cell lines express cytokeratin and androgen
receptor (AR) with Pr-111 cells demonstrating andro-
gen-dependent growth and Pr-117 cells exhibiting
androgen-responsive growth characteristics. Athymic
nude mice injected with Pr-111 cells either do not
develop tumors or develop tumors after a long latency
period of 14 weeks. Pr-117 cells, however, develop
tumors by 3 to 6 weeks, suggesting that Pr-117 cells
represent a later stage of tumor progression. These
two novel cell lines will be useful for studying early
stages of prostate tumor development and androgen
responsiveness.
Neoplasia (2002) 4, 112–120 DOI: 10.1038/sj/neo/7900210
Keywords: prostate, PIN, adenocarcinoma, cell lines, mouse.
Introduction
It is estimated that about 192,000 new cases of prostate
cancer will be diagnosed in the United States during the year
2001, and almost 32,000 deaths will result from the disease
[1]. These statistics place prostate cancer as the second
leading cause of cancer death in men in the United States. As
a result, there is an increasing need to develop early
detection techniques and assays to distinguish normal from
cancerous tissues. To improve current techniques in prostate
cancer diagnosis, additional tumor model systems need to be
developed, especially those focusing on early stages of
prostate cancer formation.
Prostatic intraepithelial neoplasia (PIN) is considered by
most to be the precursor lesion for prostate adenocarcinoma
[2]. In prostate tissue with developed carcinoma, evidence of
PIN lesions may be seen, indicating a progression from
normal glandular epithelium through PIN, to fully dediffer-
entiated prostate tissue [3]. Additionally, it has been shown
that PIN has a high predictive value as a marker for
adenocarcinoma [4]. Although mounting evidence suggests
that PIN is the precursor to adenocarcinoma, little is known
about the molecular biology of PIN and what determines
whether PIN lesions will transition into invasive carcinomas
[5]. Characterizations of PIN have generally been limited to
histologic analysis because there are few in vitro and in vivo
model systems representing this stage of prostate cancer
progression. To our knowledge, only one PIN cell line has
been established through immortalization with human papil-
loma virus (HPV) [6].
To develop a better understanding of the progression of
PIN to adenocarcinoma, animal models must be established
to facilitate analyses both in vitro and in vivo. Of the
established animal models, the transgenic mouse systems
are the most promising. Cell lines established from these
murine models can be studied in vivo without the added
complexity of using immunosuppressants in immunocompe-
tent animals receiving xenografts. An intact immune system
is essential to accurately study the growth of cell lines in the
natural host. Several transgenic prostate cancer mouse
models have been developed that express simian virus 40
large T antigen (SV40 Tag) under the control of different
promoter regulatory sequences. These include the mouse
cryptidin-2 regulatory gene [7], the rat probasin promoter
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[8 ], the human insulin growth factor -1 regulatory sequences
[9], the fetal globin promoter [10], and the model developed
by Maroulakou et al. [11], where SV40 Tag is expressed
under the regulatory control of the rat steroid binding
promoter gene, C3(1) [12]. The first four of these models
develop fully dedifferentiated prostate tumors within 2 to 3
months, making it difficult to reliably pinpoint early tumor
stages. However, C3(1) /Tag transgenic mice develop PIN
lesions from 2 to 7 months of age and invasive carcinomas
after 6 months of age [13], making the study of PIN lesions
and the establishment of cell lines from early stages of
prostate cancer feasible.
The C3(1) /Tag mouse model is the source of several cell
lines representing different levels of prostate tumor pro-
gression. These cell lines have undergone extensive
characterization and may represent an in vitro animal model
system for the study of prostate tumor progression. Cell lines
from C3(1) /Tag prostate lesions have been developed from
different stages of prostate cancer development including
prostate adenocarcinomas (Pr-142) [14] and metastases
(Pr-14C1and Pr-14C2) (unpublished data). In this study, we
describe the establishment of cell lines, Pr-111 and Pr-117,
derived from PIN lesions. In vitro analyses of these cell lines
demonstrate an epithelial origin and response to androgen.
These cell lines are valuable new reagents for studying the
PIN stage of prostate cancer development. This system may
provide extensive data on protein expression correlating to
cancer grade, as well as, a therapeutic model for an effective
treatment.
Materials and Methods
Establishment and Culture of Cell Lines
Prostates were collected immediately following sacrifice
of C3(1) /Tag transgenic male mice and carefully resected
to avoid other glandular tissues such as the urethral and
bulbourethral glands. Each prostate was divided in half;
one half was fixed in 4% paraformaldehyde for histologic
analysis and the other half was prepared for tissue culture.
For tissue culture, prostates were rinsed in phosphate-
buffered saline (PBS) (Gibco BRL, Gaithersburg, MD),
minced into 1-mm3 pieces, and centrifuged (1100 rpm at
158C for 3 minutes). The pieces of tissue were resus-
pended in growth medium (GM), PMFR-4A [15] supple-
mented with 31011 M retinoic acid (Sigma, St. Louis,
MO), 2.3106 M  - tocopherol (Sigma), 10 g/ l epi-
dermal growth factor (Collaborative, Bedford, MA), 10 g/ l
cholera toxin (List Biological, Campbell, CA), 10 mg/ l
bovine pituitary extract (Hammond Cell Tech, Alameda,
CA), 1 g/ l hydrocortisone (Sigma), 4 mg/ l insulin (Gibco),
100 mg/ l gentamycin (Sigma), 0.1 mM phosphoethanol-
amine (Sigma), and 3108 M selenous acid (Sigma). One
hundred units per milliliter of collagenase (Sigma) was
added to the medium/tissue and gently rocked overnight at
378C. After centrifugation, remaining cells were plated on
30-mm2 dishes coated with collagen (Vitrogen 100, Colla-
gen; Santa Clara, CA) in GM. Cells were trypsinized from
organoids and grown in GM+2% fetal bovine serum (FBS;
Gibco)+10 nM dihydrotestosterone (DHT) on collagen.
Immunofluorescence
Cells were plated on eight -well chamber slides, grown to
80% confluency, fixed in 208C methanol, and washed with
cold PBS. The slides were incubated 1 hour at room
temperature with blocking buffer, 5% bovine serum albumin
(BSA), 0.02% sodium azide in 1PBS, and 5% normal
donkey serum (NDS). Blocking buffer was removed from the
wells and primary antibody, diluted in primary antibody
diluting buffer (Biomed, Foster City, CA), was added and
incubated overnight at 48C. Both SV40 Tag mouse mono-
clonal antibody (Ab-2; Calbiochem, San Diego, CA) and
pan-cytokeratin rabbit polyclonal antibody (detects a range
of cytokeratins; Zymed, San Francisco, CA) were used at
1:20 dilutions. After incubation, slides were washed three
times with 1PBS and secondary antibody with either
trimethylrhodamine isothiocyanate (TRITC)- or fluorescein
isothiocyanate (FITC)-conjugated IgG (Jackson Immuno
Research, West Grove, PA) was incubated in a slide
humidifying chamber for 1 hour at room temperature in the
dark. Following incubation, the slides were washed three
times with 1PBS and allowed to dry. Two drops of Gel -
Mount (Biomed) were added to each of the slides followed
by a coverslip. The stained slides were visualized under
fluorescent microscopy (Olympus BX60) and pictures were
Figure 1. Histology of C3( 1 ) /Tag transgenic mouse prostates and growth of
cell lines in culture on collagen. H&E sections of prostates from 3- and 5 1 /2 -
month - old male transgenic mice show consecutively, (A ) low -grade PIN
demonstrating irregular spacing and cell crowding ( arrow ) and (B ) high -
grade PIN with some basal cell layer disruption and cell stratification (arrows )
( light, 100 ). Subsequent culture of isolated cells on collagen in GM+2%
FBS resulted in two cell lines: (C ) Pr -111 (passage 9 ) cell line from the low -
grade PIN lesion and (D ) Pr -117 (passage 9 ) cell line from the high - grade
PIN lesion (phase contrast,  200 ).
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taken with an Olympus C-35AD-4 automatic camera with
200 ASA Kodak color print film with a 40 objective lens.
Western Blot Analysis
Total cell extracts were isolated using the RIPA protocol
(Santa Cruz, Santa Cruz, CA). Cell extract concentrations
were determined by a BioRad protein assay method
(BioRad, Hercules, CA) and compared to a BSA stand-
ardization curve. Ten micrograms total protein extracts in 3
sample buffer (150 mM Tris, pH 6.8; 6% SDS; 30% glycerol;
6 mM EDTA; 10%  -mercaptoethanol; 0.01% bromophenol
blue) was loaded on an 8% tris -glycine denaturing gel
( iGels, Salt Lake City, UT). Gels were stained with
coomassie blue (Sigma) or transferred to a nitrocellulose
membrane filter (Novex, San Diego, CA) for immunoblotting.
After transfer, the filter was blocked in 1PBS plus 0.5%
Tween-20 (PBS-T) and 5% nonfat dry milk at room
temperature for 1 hour. Filters were washed with 1PBS-T
and incubated overnight at 48C with either a 1:100 dilution of
anti–SV40 Tag mouse mAb or 1:200 dilution of anti–
vimentin mouse mAb (Zymed) in 1PBS-T with 0.02%
sodium azide. The filter was washed and incubated with goat
anti–mouse IgG peroxidase-conjugated secondary anti-
body (Boehringer Mannheim, Indianapolis, IN) diluted
1:6667 in 1PBS-T for 1 hour at room temperature. The
filter was exposed to autoradiography following treatment
with enhanced chemiluminescence according to the manu-
facturer’s protocol (NEN, Boston, MA).
Proliferation Assay
Cells were plated at 1104 cells /well in 24-well dishes in
eitherGM+2%FBS+DHT (GM+2%)orDulbecco’smodified
Eagle’s medium (DMEM)+10% FBS (DMEM+10%). Every
24 hours, cells were trypsinized and counted using a
hemacytometer. Experiments were based on an average
of six wells in two separate experiments. The doubling
times were determined for each cell line in each medium.
Growth on Matrigel
Cells (1104) were plated on Matrigel (Becton Dickinson,
Bedford, MA) in 30-mm2 dishes (400 l Matrigel /30 mm2) in
DMEM+10% or GM+2% medium. Cells were fed every
3 days before photographing on a Zeiss Axiovert 25
microscope with a Nikon FE2 35-mm camera using TMAX
100 ASA Kodak black and white professional film.
Nude Mice Studies
Cells (1106 cells /0.2 ml PBS) were injected subcuta-
neously (s.c. ) into each of five, 8-week-old male athymic
mice. Tumors were measured weekly and size was
Figure 2. Cytokeratin and SV40 Tag expression in Pr -111 and Pr - 117 cells
using immunofluorescence. Cells ( 1105 cells /well ) were grown on eight -
well chamber slides and exposed to antibodies for pan - cytokeratin ( antibody
that detects a range of cytokeratins ) and SV40 Tag. Pr - 111 and Pr - 117 cells
show expression of cytokeratin and the SV40 Tag transgene. The epithelial
A549 cell line (human lung carcinoma ) represents a positive control for
cytokeratin; NIH3T3 (mouse fibroblast cell line ) is a negative control for
cytokeratin; Pr - 142 (mouse prostate adenocarcinoma cell line ) is the positive
control for SV40 Tag ( fluorescent, 400 ).
Figure 3. Protein expression analysis of transgenic mouse prostate cell lines.
Western blot analysis shows that the Pr - 111 and Pr - 117 cell lines express
SV40 Tag (A ), and do not express the stromal cell marker, vimentin (B ). (C )
A matched gel was stained with coomassie blue for loading efficiency. Pr - 142
is used as the negative control for vimentin and positive control for SV40 Tag,
whereas NIH3T3 is used as the positive control for vimentin and negative
control for SV40 Tag.
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determined by the formula: largest diameter(smallest
diameter)20.4 [16].
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR)
The presence of androgen receptor (AR) was deter-
mined by RT-PCR using mouse-specific PCR primers.
One microgram of total RNA was purified with amplification-
grade DNAse I (Gibco) according to manufacturer’s
directions and reverse transcribed into cDNA using Super-
script II Reverse Transcriptase (Gibco). One microliter of
cDNA (1:5 dilution) was amplified with mouse-specific AR
primers (50 primer: CGACTACTACAACTTTCCGC; 30 pri-
mer: TCATCTCCACAGATCAGGCA) with the following
conditions: 35 cycles at 948C for 1 minute, 588C for
2 minutes, and 728C for 3 minutes. The internal control,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH),
was amplified with mouse-specific PCR primers (Clontech,
Palo Alto, CA). One microliter of cDNA (1:5 dilution) was
amplified for 28 cycles at 948C for 30 seconds, 608C for
1 minute, and 728C for 2 minutes. The PCR products were
run on 1% agarose gels stained with ethidium bromide.
Androgen Dependence Assay
Cells (1103) were plated in each of eight wells on 96-
well plates. The cells were incubated in medium (GM or
DMEM) supplemented with charcoal -stripped FBS (CS-
FBS; Cocalico Biologicals, Reamstown, PA) and in control
medium: GM+2% or DMEM+10%. Cells were fed with
appropriate medium (with and without androgens) before
the 3-(4,5-dimethylthiazol -2-yl ) -2,5-diphenyltetrazolium
bromide (MTT) assay [17], which was performed on a 96-
Figure 4. Growth curve for Pr - 111 and Pr - 117 cell lines. Twenty - four -well
dishes coated with collagen were seeded with 510 3 cells /well in GM+2% or
DMEM+10%. Cells were trypsinized and counted with a hemocytometer
every 24 hours. Pr -111 cells have a significantly slower growth rate compared
to Pr - 117 cells in both media. Each point represents an average of six wells in
three independent experiments.
Figure 5. Morphological characteristics of Pr - 111 and Pr - 117 cells grown on plastic and Matrigel. Cells ( 510 3 ) were plated on 30 -mm2 plastic tissue culture
dishes with and without 400 l of the ECM, Matrigel. Both Pr - 111 (A ) and Pr -117 (B ) cells exhibit cobblestone morphology when grown on plastic ( phase contrast,
200 ). (A ) Pr - 111 demonstrates glandular - type growth characteristics on Matrigel in both GM+2% and DMEM+10%; (B ) Pr - 117 cells show ductal growth on
Matrigel in GM+2% and glandular growth in DMEM+10% (varel, 200 ).
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well plate every 4 days. Media were aspirated and replaced
with medium containing 0.5 mg/ml MTT (Sigma) and
incubated for 3 hours. After incubation, the medium was
removed and replaced with isopropanol to dissolve the
formazan crystals. The wells were read and analyzed at
570 nm on a Model 550 Microplate Reader (BioRad) using
the Microplate Manager 4.0 software (BioRad).
Results
Establishment of Cell Lines from C3(1) /Tag Transgenic
Mice PIN Lesions
C3(1) /Tag transgenic mouse prostate tissue was care-
fully resected from 3- and 5 1/2-month-old mice. One half
of each section was stained with hematoxylin and eosin
(H&E) and histologic analysis showed that the 3-month-old
prostate tissue contained low-grade PIN lesions exhibiting
irregular spacing and cell crowding (arrow, Figure 1A ),
whereas the 5 1/2-month-old tissue contained high-grade
PIN lesions with some basal cell layer disruption and cell
stratification (arrows, Figure 1B ). The remaining prostate
tissue from each mouse was used to establish two cell lines,
Pr-111 ( from low-grade PIN) and Pr-117 ( from high-grade
PIN). The cell lines were isolated and maintained in culture
on collagen in GM+2% FBS. GM is a growth medium
designed to encourage growth of normal prostate epithelial
cells and inhibit growth of stromal cells [15]. In addition, our
standard GM+2% medium contains 10 nM DHT. The Pr-
111 and Pr-117 cells acquire a cobblestone- like morphol-
ogy, typical of epithelial cells, when grown to confluence on
collagen (Figure 1;C and D ).
Immunofluorescent Staining of Pr-111 and Pr-117 Cells
After establishing the cell lines in culture, Pr-111 and Pr-
117 cells were analyzed for cell marker expression by
immunofluorescence. As expected for cells of epithelial
origin, both Pr-111 and Pr-117 cells express cytokeratins in
the cytoplasm as detected by a pan-cytokeratin primary
antibody (Figure 2 ). In contrast, mouse NIH 3T3 fibroblasts
show no cytokeratin expression, whereas, positive control
cell lines, A549 (a human lung epithelial cell line) and Pr-142
(a mouse prostate adenocarcinoma cell line derived from a
C3(1) /Tag transgenic mouse [14] ), exhibit cytokeratin
immunofluorescent staining.
To show transgene expression, immunofluorescence on
Pr-111 and Pr-117 cells was performed using a monoclonal
Figure 7. Androgen regulation in Pr - 111 and Pr -117 cells. Ninety - six -well
plates were plated with 110 3 cells /well under various media conditions.
Cells were quantified by an MTT assay every 4 days for cell growth. (A ) Pr -
111 cells show a significant response to androgen depletion (GM+2% CS-
FBS and DMEM+10% CS-FBS) when compared to control conditions
(GM+2% and DMEM+10%). (B ) Pr - 117 cells show androgen - independent
growth in the GM+2% CS-FBS but not in the DMEM+10% CS-FBS. (C )
When androgens are added back to the cells in DMEM+10% CS-FBS on day
22, Pr - 117 cells resume replicating and Pr - 111 cells did not. This is a
representative of repeated experiments each showing similar results.
Figure 6. AR expression of Pr -111 and Pr - 117 cell lines by RT -PCR. Total
RNA was reverse transcribed into cDNA and amplified using specific mouse
primers for AR. Both Pr -111 and Pr -117 cell lines express high levels of AR.
Ur - 12 (mouse urethral tumor cell line ) does not exhibit AR expression by RT -
PCR (unpublished data ). GAPDH was used as the internal control. The PCR
products were separated on a 1% agarose gel and stained with ethidium
bromide.
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antibody to SV40 Tag. Both Pr-111 and Pr-117 cells exhibit
100% nuclear SV40 Tag expression (Figure 2 ). As a positive
control, Pr -142 cells show SV40 Tag expression, whereas
NIH3T3 and A549 are negative, indicating that these cell
lines did not originate from a SV40 Tag model system
(Figure 2 ).
Western Blot Analysis of Pr-111 and Pr-117 Cells
Total cell protein was examined by Western blot analysis
using a monoclonal antibody for the nuclear protein, SV40
Tag. Figure 3A demonstrates expression of the 92-kDa
SV40 Tag protein in Pr-111 and Pr-117 cell lines as well as
in Pr-142 (positive control ). SV40 Tag expression levels
appeared lower in Pr-111 cells (potential PIN cell line)
compared with Pr-117 and Pr-142 cells. As expected, no
SV40 Tag expression was detected in NIH3T3 and A549
cells.
Western blot analysis was also used to detect vimentin,
a protein expressed by cells of mesenchymal origin, such
as fibroblasts and smooth muscle cells. Figure 3B shows
that Pr-111 and Pr-117 cell lines do not express vimentin.
In contrast, the fibroblastic NIH3T3 cells show the
expected 57-kDa vimentin band (Figure 3B ). The amount
of protein loaded in each lane was compared with a
coomassie blue staining of a matched SDS-PAGE gel
(Figure 3C ).
Growth Rates for Pr-111 and Pr-117 Cell Lines
Once isolated from PIN lesions, Pr-111 and Pr-117 cells
were cultured on collagen in GM+2%. Growth rates were
determined for the cell lines grown in two different media,
GM+2% or DMEM+10%, and counted every 24 hours.
The doubling time for the Pr-111 cell line in GM+2% is
37.2 hours, whereas it is only 20.8 hours for the Pr-117 cell
line. When grown in DMEM+10%, the doubling times were
46.4 hours for Pr-111 cells and 25.6 hours for Pr-117 cells.
In both media, Pr-111 cells show a significantly slower
growth rate compared with Pr-117 cells (Figure 4 ). In
addition to having a higher growth rate than Pr-111 cells, Pr -
117 cells grow at a rate considerably greater than Pr-142
cells (data not shown).
Morphological Characteristics of Pr-111 and Pr-117 on
Matrigel
Pr-111 and Pr-117 cells were grown on two different
substrates [plastic or the extracellular matrix (ECM),
Matrigel ] to determine if the cells would undergomorphologic
alterations depending on the media.
When grown on plastic in either GM+2% and
DMEM+10%, both Pr-111 and Pr-117 cell lines appear as
cuboidal monolayers (Figure 5;A and B ). However, when
grown on Matrigel, the morphology and proliferative abilities
over time change dramatically depending on which media is
used. Pr-111 cells cultured in either media appear acinar
and grow as aggregates (Figure 5A ). However, these cells
proliferate more rapidly in GM+2%, consistent with prolifer-
ation assay results (Figure 4 ). Pr -117 cells show acinar
characteristics in DMEM+10% (Figure 5B ), but form long
tube- like ductal structures in the GM+2%, as previously
described for the mouse prostate adenocarcinoma cell line,
Pr-142 [14].
Androgen Regulation in Pr-111 and Pr-117 Cells
Normal prostate cell growth and function is dependent on
the interaction of androgens with the AR. In prostate cancer,
a correlation has been shown between tumor aggressive-
ness and androgen independence. The presence of AR by
RT-PCRwas carried out to determine if our potential PIN cell
lines express AR transcripts. Analysis revealed that both Pr-
111 and Pr-117 cell lines express AR, as well as the
adenocarcinoma cell line, Pr-142 (Figure 6 ). The Ur-12 cell
line, a mouse urethral tumor cell line derived from the C3(1) /
Tag transgenic mouse model (unpublished data), shows no
AR expression. GAPDH was used as an internal control.
In addition, we wanted to characterize the functionality of
the receptor by determining the ability of the Pr-111 and Pr-
117 cells to grow with and without androgens in an in vitro
androgen-ablation assay. Cells were plated on 96-well
dishes in four types of media: GM+2% (standard medium,
which includes DHT), GM+2% CS-FBS (charcoal stripping
removes steroidal hormones such as androgen and estro-
gen), DMEM+10% (standard medium, which does not
include additional DHT), and DMEM+10% CS-FBS. Every
Table 1. Tumorigencity of Prostate Cells Lines Injected into Male, Athymic Mice.
Cell Line Number of Cells
Injected / 0.2 ml PBS
Number of Mice
with Tumors
Time to Onset of
Tumors (Weeks )
Average Size of
Tumors at 6 Weeks (cm3 )
Pr -111 (8 )* 1106 3 /5 32 NDy
Pr -111 (12 )* 1106 4 /5z 14 0
Pr -111 (8 )* 1106 8 /8 6 ND
Pr -111 (12 )* 1106 5 /5 3 4.1
Pr -142
x 1106 1 /1 2 0.18
*Cell passage.
yND=not determined.
zAverage tumor volume at 23 weeks measured only 0.14 cm3.
xIn other experiments, 100% of mice injected with 2106 cells resulted in tumor formation by 2 to 3 weeks 14.
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4 days, cells were quantified using an MTT assay to measure
cell viability.
In control media (GM+2% and DMEM+10%), Pr-111
and Pr-117 cells grew in a manner consistent with the
proliferation assay (Figure 4 ). The Pr-111 cells showed a
significantly reduced growth rate in the GM+2% CS-FBS
and interestingly, were unable to survive in the DMEM+10%
CS-FBS (Figure 7A ). As expected of a more aggressive cell
type, Pr-117 cells maintained a near-normal growth rate in
the GM+2% CS-FBS, but like Pr-111 cells, Pr -117 cells
stopped growing in the DMEM+10% CS-FBS (Figure 7B ).
On day 22, DHT was added back to the DMEM+10% CS-
FBS and within 4 days, Pr-117 cells resumed proliferating as
normal (Figure 7C ). However, adding back DHT did not
increase the number of Pr-111 cells (Figure 7C ), indicating
that these cells had not survived the extended time without
androgens, and implying an androgen- responsive/depend-
ent phenotype.
Tumorigenicity of Pr-111 and Pr-117 Cells in Nude Mice
To characterize the tumorigenicity of Pr-111 and Pr-117
cell lines in vivo, 1106 cells were injected s.c. in the right
flank of 8-week-old male athymic mice and tumor growth
was observed. Utilizing early passage Pr-111 cells
(passage 8), no tumors formed until 32 weeks after
injection, and then in only three of five mice injected. With
passage 12 cells, tumors developed by 14 weeks in four of
five mice injected (see Table 1). In contrast, Pr-117 cells
formed solid tumors in all mice injected within 6 weeks
(passage 8) or 3 weeks (passage 12) postinjection.
Interestingly, analyses of the lungs of mice injected with
passage 12 Pr-117 cells were found to have numerous
metastases (data not shown). Histologic analysis indicated
that all growths were adenocarcinomas (Figure 8 ). The
tumorigenicity of the Pr-111 cells in nudemice is significantly
reduced compared to the Pr-117 cells.
Discussion
Existing in vitro systems for the study of prostate cancer use
cell lines developed from late-stage disease [18–22]. To
understand the development and progression of prostate
cancer at early stages, we have developed cell lines that
appear to represent both early - and late-stage disease from
the C3(1) /Tag transgenic mouse model. The C3(1) /Tag
transgenic mouse model was developed using a transgene
composed of the promoter region of the C3(1) rat steroid
binding gene fused to the regulatory sequence of SV40 Tag
[11]. In addition to exhibiting tumorigenesis in prostate and
mammary tissue,C3(1) /Tag transgenic mice have evidence
of SV40 Tag expression in several other tissues, but it has
been shown that SV40 Tag is not sufficient in these tissues to
establish malignancies [11]. In the C3(1) /Tag transgenic
model for prostate cancer, PIN develops in 2 to 7 months and
adenocarcinomas arise after 6 to 12 months [13]. The
extended time needed for these transgenic mice to develop
carcinomas make this model ideal for studying the various
early genetic changes prostate cells undergo en route to
acquiring an invasive phenotype in vivo [23]. In addition, the
predictability of tumor progression in this model allows for the
isolation of tissues and cells at different stages for in vitro
studies.
Several studies of human patients strongly suggest that
PIN is the precursor lesion to prostate adenocarcinoma.
These studies compare PIN to both cancerous and normal
tissues and fully demonstrate that characteristics of PIN
lesions (e.g., proliferation rates, protein expression, etc. ) fall
between those of normal and cancerous prostate tissues
[4,24-26]. To help in developing early-detection assays by
studying early-stage or precancerous tissues, we have
focused our efforts toward establishing a cell line from
prostates with PIN lesions.
In this study, we isolated and characterized two mouse
prostate cell lines, Pr-111 and Pr-117. These cell lines were
established from the prostates of 3- and 5 1/2-month-old,
male C3(1) /Tag transgenic mice, with the intent to develop
cell lines representing low-grade PIN (3 months) and high-
Figure 8. Histological analysis of tumors from nude mice studies. (A ) H&E
staining of a small growth (1.0 cm3 at 23 weeks ) resulting from Pr - 111 cells
injected s.c. into nude mice. Cells exhibit variation in size of the nucleus, as
well as sporadically stained chromatin ( arrows ). (B ) Darkly stained cells
demonstrating increased chromatin content ( arrows ) of a tumor ( 11.6 cm3 at
8 weeks ) that developed at the injection site with Pr -117 cells ( light, 400 ).
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grade PIN (5 1/2 months). As we discovered, PIN tissue
was difficult to grow in culture because like normal mouse
prostate tissue, most cells do not survive their first passage
with trypsin. Pr -111 and Pr-117 represent cell lines that
were successfully passaged after nearly 50 individual
attempts. Based on our results, the Pr-111 cell line appears
to represent a PIN cell line, whereas the Pr-117 cell line has
the characteristics of a more aggressive adenocarcinoma.
Immunofluorescence studies demonstrate that Pr-111 and
Pr-117 cell lines express cytokeratin, an epithelial cell
marker, but not vimentin, a stromal cell marker. Immuno-
fluorescence and Western blot analyses also show that both
Pr-111 and Pr-117 cells express SV40 Tag. Three cell lines
derived from the C3(1) /Tag transgenic model, Pr -111 (a
PIN cell line), Pr -117, and Pr-142 (a mouse prostate
adenocarcinoma cell line [14] ), show an increasing level of
SV40 Tag expression, a trend that has also been demon-
strated by immunohistochemical staining of C3(1) /Tag
mouse PIN and adenocarcinoma tissue [27]. This further
suggests that the Pr-111 cell line represents an early stage
of prostate cancer progression. SV40 Tag has been shown
to bind and inactivate p53 and Rb function [28,29]. Due to
the lower expression level of SV40 Tag, our data suggest
that Pr-111 cells remain under some level of tumor
suppression by p53 and/or Rb.
In addition to demonstrating the epithelial status and
expression levels of SV40 Tag, we also looked at the
growth rates of these two cell lines. Pr-111 cells show a
significantly slower growth rate compared to Pr-117 cells in
both media analyzed. Interestingly, the Pr-117 cells have a
faster growth rate than all other adenocarcinoma cell lines
established from the C3(1) /Tag transgenic mouse model
(data not shown).
The growth characteristics of the Pr-111 and Pr-117 cell
lines were also evaluated on Matrigel, an ECM. The growth
of Pr-111 cells on Matrigel shows acinar /glandular structure
formation in both GM+2% and DMEM+10%, but as
demonstrated in the proliferation assay, Pr-111 cells did
not grow as well in DMEM+10%. The Pr-117 cells show
acinar /glandular growth in DMEM+10%, but demonstrate
ductal structures in GM+2%, a characteristic described by
Jorcyk et al. [14] with Pr-142, the prostate adenocarcinoma
cell line. GM+2% is a complex medium, containing many
added factors, which has led to studies to determine which
factors are contributing to the ductal formation of adenocar-
cinoma- like cell lines, such as Pr-117 and Pr-142.
In humans, as well as mice, the cells of the prostate
are under androgen regulation. The progression and
staging of prostate cancer can be determined by the
status of AR expression and response to androgen
ablation therapy. Pr-111 cells express AR and demon-
strate androgen-responsive/dependent growth in culture.
The androgen responsiveness, along with a limited tumori-
genic ability in vivo, suggests that this cell line is in an early
stage of tumor progression, that is, PIN. However, the Pr-
117 cells express AR, but exhibit androgen- independent
growth in the GM+2%, and have a high tumorigenic rate.
This adenocarcinoma cell line, with further investigation, may
contribute to an understanding of androgen- independent
prostate cancer progression.
To further characterize the Pr-111 and Pr-117 cell lines,
we evaluated nude mice injected with the cell lines for tumor
growth. From our tumorigenicity assays, we determined that
the passage number of the cells was related to the time
required for tumor growth in nude mice. With the Pr-111 cell
line, early passage cells did not form tumors for over
32 weeks, whereas later passage cells developed small,
slow-growing cancerous growths by 14 weeks. All tumors
were analyzed histologically and determined to be adeno-
carcinomas. This further supports the prostate epithelial
origin of Pr-111 cells. As the precursor lesion to carcinoma, it
is expected that over time, PIN will convert into the
cancerous phenotype through additional mutations, which
may be the case in our nude mice studies utilizing both early
and later passages. The control cell line injections (Pr-142)
developed tumors within 2 to 3 weeks, which is a significantly
faster rate than the Pr-111 cell line. In contrast to the Pr-111
cells, all nude mice injected with Pr-117 cells developed
adenocarcinomas within 3 to 6 weeks. Additionally, all mice
injected with Pr-117 cells and analyzed had gross and
histologic evidence of metastases in the lungs. These data
may suggest that Pr-117 cells were derived from aggressive
carcinoma cells not present in the histologic analysis of the
high-grade PIN lesion, or had progressed dramatically in
culture from the cells of the original high-grade PIN lesion.
The development and characterization of the androgen-
dependent mouse PIN cell line, Pr-111, and the androgen-
responsive aggressive adenocarcinoma cell line, Pr-117,
allows for comparison studies between normal prostate cells,
PIN cells (Pr -111), adenocarcinoma cells (Pr -142 [14], Pr-
117), and metastatic adenocarcinoma cells (Pr -14C1, Pr-
14C2) (unpublished data) in vitro. These cells can be
transferred easily into the C3(1) /Tag transgenic mouse
model system for in vivo analyses. The cell lines described
here contribute to the C3(1) /Tag transgenic mouse model
system and will be used for comparison analyses between all
cell lines of the model system to investigate prostate-specific
proteins that could potentially be used as markers for cancer
progression.
Further in vitro and in vivo studies into the mechanisms
involved in the changes of the cells from normal tissue to
metastatic disease are underway to extend the character-
ization of the cell lines derived from the C3(1) /Tag trans-
genic model system.
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